| scholarly article | Q13442814 |
| P50 | author | Klaus Busam | Q42745680 |
| Thomas Wiesner | Q42760108 | ||
| Rajmohan Murali | Q37384957 | ||
| Boris C. Bastian | Q41044834 | ||
| P2093 | author name string | Klaus Busam | |
| Heinz Kutzner | |||
| Lorenzo Cerroni | |||
| Isabella Fried | |||
| P2860 | cites work | The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment | Q48704983 |
| Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. | Q50447893 | ||
| Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms. | Q53359204 | ||
| Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas | Q84242627 | ||
| Germline mutations in BAP1 predispose to melanocytic tumors | Q24594891 | ||
| Mutations in GNA11 in uveal melanoma | Q24625723 | ||
| Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi | Q24646052 | ||
| Distinct sets of genetic alterations in melanoma | Q29614965 | ||
| Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome | Q33638348 | ||
| Spitz naevus: histological features and distinction from malignant melanoma | Q34037406 | ||
| High frequency of BRAF mutations in nevi | Q34160519 | ||
| Somatic activation of KIT in distinct subtypes of melanoma | Q34569987 | ||
| Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features | Q35829451 | ||
| The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin | Q36092451 | ||
| HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. | Q37792720 | ||
| The T1796A mutation of the BRAF gene is absent in Spitz nevi | Q40529281 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 818-830 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | The American Journal of Surgical Pathology | Q7713508 |
| P1476 | title | A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression | |
| P478 | volume | 36 |
| Q41231769 | A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus |
| Q38814312 | A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment |
| Q39071774 | A population-based analysis of germline BAP1 mutations in melanoma. |
| Q35751775 | A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERT |
| Q38394141 | A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile. |
| Q90642244 | Altered Nuclear Expression of the Deubiquitylase BAP1 Cannot be Used as a Prognostic Marker for Canine Melanoma |
| Q33911349 | Ambiguous melanocytic tumors with loss of 3p21. |
| Q90604719 | An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin |
| Q90702168 | An update on molecular alterations in melanocytic tumors with emphasis on Spitzoid lesions |
| Q47610925 | Atypical ALK-positive Spitz tumors with 9p21 homozygous deletion: Report of two cases and review of the literature. |
| Q50068785 | Atypical Melanocytic Proliferations: A Review of the Literature |
| Q85236158 | BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations |
| Q37221089 | BAP1 and cancer |
| Q36384018 | BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs |
| Q28397624 | BAP1 hereditary cancer predisposition syndrome: a case report and review of literature |
| Q39290955 | BAP1 mutations in high-grade meningioma: implications for patient care |
| Q53515181 | BAP1-deficient and VE1-negative atypical Spitz tumor. |
| Q47135418 | BAP1: case report and insight into a novel tumor suppressor. |
| Q90223367 | BRCA1-associated protein 1 expression and prognostic role in prostate adenocarcinoma |
| Q33731436 | Biologically distinct subsets of nevi |
| Q38119922 | Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA. |
| Q34661027 | Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions. |
| Q35433876 | Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions |
| Q47690363 | Compound clear cell sarcoma misdiagnosed as a Spitz nevus |
| Q28397229 | Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases |
| Q42547095 | Dermatopathology quiz: A dome-shaped papule on the cheek |
| Q36752423 | Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update |
| Q38833186 | Differential diagnosis of Spitzoid melanocytic neoplasms |
| Q28087169 | Emerging clinical applications of selected biomarkers in melanoma |
| Q47370293 | Evaluating melanocytic lesions with single nucleotide polymorphism (SNP) chromosomal microarray |
| Q37288289 | Fluorescence in situ hybridization testing of chromosomes 6, 8, 9 and 11 in melanocytic tumors is difficult to automate and reveals tumor heterogeneity in melanomas |
| Q99616838 | Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes |
| Q38846801 | Gene of the month: BAP1. |
| Q38186704 | Genetic alterations and personalized medicine in melanoma: progress and future prospects |
| Q47932446 | Genetic and clinico-pathologic analysis of metastatic uveal melanoma |
| Q53356770 | Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations. |
| Q33849590 | Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment |
| Q38771870 | Genetic progression of malignant melanoma |
| Q28085036 | Genetics of melanocytic nevi |
| Q60956654 | Genomic Landscape of Spitzoid Neoplasms Impacting Patient Management |
| Q36755569 | Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy |
| Q36599690 | Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling |
| Q53533612 | Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome. |
| Q45361587 | Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area |
| Q33854847 | Kinase fusions are frequent in Spitz tumours and spitzoid melanomas |
| Q34283714 | Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing |
| Q36898293 | Lack of SF3B1 R625 mutations in cutaneous melanoma |
| Q35959422 | Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma |
| Q28384496 | Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma |
| Q28387556 | Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology |
| Q33710012 | Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma |
| Q92540910 | Melanocytic Skin Tumors: Does the Molecular Progression Model Fit With the Routine Clinicopathological Practice? |
| Q92540935 | Melanocytic Skin Tumors: Genetic Aberrations and Clinicopathological Classification |
| Q34044830 | Melanoma genetics |
| Q42700777 | Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function. |
| Q55031139 | Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation. |
| Q54313630 | NRAS-mutated melanocytic BAP1-associated intradermal tumor (MBAIT): a case report. |
| Q48353431 | Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: A pilot study. |
| Q38122565 | PBRM1 and BAP1 as novel targets for renal cell carcinoma |
| Q39267197 | Paediatric melanoma |
| Q47818895 | Pathology and genomics of pediatric melanoma: A critical reexamination and new insights. |
| Q49480419 | Pediatric melanoma: incidence, treatment, and prognosis |
| Q40952188 | Primary dermal melanoma: a West Australian cohort |
| Q91755813 | Prioritization and comprehensive analysis of genes associated with melanoma |
| Q38794945 | Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens |
| Q88457630 | Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma |
| Q26740631 | Recent advances in molecular genetics of melanoma progression: implications for diagnosis and treatment |
| Q38120938 | Regulation of proteolysis by human deubiquitinating enzymes |
| Q36092850 | Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma |
| Q40000142 | Spitz Tumors: Comparison of Histological Features in Relationship to Immunohistochemical Staining for ALK and NTRK1. |
| Q92407210 | Spitz melanoma is a distinct subset of spitzoid melanoma |
| Q45295435 | TERT promoter mutations are not always associated with poor prognosis in atypical spitzoid tumors |
| Q38214084 | The Importance of Multidisciplinary Approach in Early Detection of BAP1 Tumor Predisposition Syndrome: Clinical Management and Risk Assessment |
| Q36798179 | The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia |
| Q38917126 | The role of eIF4E in response and acquired resistance to vemurafenib in melanoma |
| Q89748146 | Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis |
| Q34928118 | Update on Molecular Pathology of Cutaneous Melanocytic Lesions: What is New in Diagnosis and Molecular Testing for Treatment? |
| Q53637446 | [Morphological and genetic aspects of Spitz tumors]. |
Search more.